Dasatinib, nilotinib and standard-dose imatinib for the first-line treatment of chronic myeloid leukaemia: systematic reviews and economic analyses. (Q38058383)
Jump to navigation
Jump to search
scientific article published on January 2012
Language | Label | Description | Also known as |
---|---|---|---|
English | Dasatinib, nilotinib and standard-dose imatinib for the first-line treatment of chronic myeloid leukaemia: systematic reviews and economic analyses. |
scientific article published on January 2012 |
Statements
Dasatinib, nilotinib and standard-dose imatinib for the first-line treatment of chronic myeloid leukaemia: systematic reviews and economic analyses (English)
L Crathorne
T Jones-Hughes
L Osipenko
M Venkatachalam
C Rudin
O Ukoumunne